“光脚不怕穿鞋的”具象化了

Pfizer cuts full-year outlook due to declining sales of Covid-19-related products_蜘蛛资讯网

l vaccination period just began and the New York City drugmaker said that it's too soon to get a handle on vaccination rates for the year.Full-year revenue for Paxlovid and Comirnaty is expected

omirnaty is expected to be approximately $12.5 billion, short $9 billion of what it had expected. Pfizer is lowering its full-year revenue expectations for Paxlovid by approximately $7 billion. That n

当前文章：http://aoal9.muruoyu.cn/xh6/nt2mak3.html

发布时间：22:40:31